CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 24, 2015	Oct. 25, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 4,430	$ 3,879
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,958	5,903
Non-cash share-based compensation	740	790
Deferred taxes	(1,017)	(809)
Provision to value inventories at LIFO	100	100
Changes in assets and liabilities:
Merchandise inventories	(1,159)	(633)
Patronage dividend receivable	(4,553)	(4,293)
Accounts payable to Wakefern	(68)	(3,041)
Accounts payable and accrued expenses	7	(4,130)
Accrued wages and benefits	(1,930)	(3,085)
Income taxes payable/receivable	4,112	2,819
Other assets and liabilities	(1,205)	2,551
Net cash provided by operating activities	5,415	51
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(5,328)	(4,386)
Proceeds from Sale of Property, Plant, and Equipment	900	0
Investment in notes receivable from Wakefern	0	(410)
Net cash used in investing activities	(4,428)	(4,796)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	0	13
Excess tax benefit related to share-based compensation	0	7
Principal payments of long-term debt	(223)	(232)
Dividends	(3,164)	(3,133)
Payments for Repurchase of Common Stock	$ (490)	0
Document Period End Date	Oct. 24, 2015
Net cash used in financing activities	$ (3,877)	(3,345)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(2,890)	(8,090)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	59,040	77,352
CASH AND CASH EQUIVALENTS, END OF PERIOD	56,150	69,262
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:
Interest	1,128	1,082
Income taxes	100	1,498
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)	$ 717	$ 738